Leaflet CINACALCET PHARMAZAC 60mg film-coated tablets
Product code: W65843001 Quantity: 14
Indicated for: hyperparathyroidism
Route of administration: oral
Substance: cinacalcet (thyroid hormone)
ATC: H05BX01 (Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Other anti-parathyroid agents)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Cinacalcet is a medication used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis, as well as for the treatment of hypercalcemia associated with parathyroid carcinoma. It works by increasing the sensitivity of calcium receptors in the parathyroid glands, thereby reducing parathyroid hormone (PTH) levels.
The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the prescribed dosage and undergo regular check-ups to monitor calcium and PTH levels.
Patients should be aware of potential side effects, such as nausea, vomiting, or hypocalcemia. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, vomiting, and hypocalcemia. In rare cases, severe reactions such as seizures or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about CINACALCET PHARMAZAC 60mg
- Substance: cinacalcet
- Date of latest medicines list: 01-08-2019
- Product code: W65843001
- Concentration: 60mg
- Pharmaceutical form: film-coated tablets
- Quantity: 14
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for cinacalcet
Concentrations available for cinacalcet
- 30mg
- 60mg
- 90mg